Ridker, Paul M
Brigham and Women's Hospital · Harvard University
167 papers on CoChatORCID 0000-0003-1249-4522
Most cited papers
- Verified
Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial
Pradhan, A. D., Everett, B. M., Cook, N. R., Rifai, N., & Ridker, P. M. (2009) · JAMA
Diabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases
Cited by 117
- Verified
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy
Ridker, P. M., Tuttle, K. R., Perkovic, V., Libby, P., & MacFadyen, J. G. (2022) · European Heart Journal
Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases
Cited by 117
- Verified
Socioeconomic Status and Incident Type 2 Diabetes Mellitus: Data from the Women's Health Study
Lee, T. C., Glynn, R. J., Peña, J. M., Paynter, N. P., Conen, D., Ridker, P. M., Pradhan, A. D., Buring, J. E., & Albert, M. A. (2011) · PLoS ONE
Health disparities and outcomesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 116
- Verified
Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?
Ridker, P. M. (2008) · Clinical Chemistry
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 114
- Verified · note
From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
Ridker, P. M. (2020) · Circulation
Health and Medical Research ImpactsHistory of Science and Medicine
Cited by 111
- Verified
Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women
Lawler, P. R., Akinkuolie, A. O., Ridker, P. M., Sniderman, A. D., Buring, J. E., Glynn, R. J., Chasman, D. I., & Mora, S. (2017) · Clinical Chemistry
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 104
- Verified
Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women
Weinberg, M. E., Manson, J. E., Buring, J. E., Cook, N. R., Seely, E. W., Ridker, P. M., & Rexrode, K. M. (2006) · Metabolism
Hormonal and reproductive studiesOvarian function and disorders
Cited by 101
- Verified
Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications.
Sterenborg, R. B. T. M., Steinbrenner, I., Li, Y., Bujnis, M. N., Naito, T., Marouli, E., Galesloot, T. E., Babajide, O., Andreasen, L., Astrup, A., et al. (2024) · Nature Communications
Genetic Associations and EpidemiologyThyroid Disorders and Treatments
Cited by 79
- Verified
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial
Nissen, S. E., Lincoff, A. M., Wolski, K., Ballantyne, C. M., Kastelein, J. J. P., Ridker, P. M., Ray, K. K., McGuire, D. K., Mozaffarian, D., Koenig, W., et al. (2021) · JAMA Cardiology
Fatty Acid Research and HealthLipoproteins and Cardiovascular Health
Cited by 76
- Verified
Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state
White, K. T., Moorthy, M. V., Akinkuolie, A. O., Demler, O., Ridker, P. M., Cook, N. R., & Mora, S. (2015) · Clinical Chemistry
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 74
- Verified
Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium
Merino, J., Dashti, H. S., Li, S. X., Sarnowski, C., Justice, A. E., Graff, M., Papoutsakis, C., Smith, C. E., Dedoussis, G. V., Lemaitre, R. N., et al. (2019) · Molecular Psychiatry
Genetic Associations and EpidemiologyNutrition, Genetics, and Disease
Cited by 66
- Verified
Association of the Mediterranean Diet With Onset of Diabetes in the Women’s Health Study
Ahmad, S., Demler, O. V., Sun, Q., Moorthy, M. V., Li, C., Lee, I.-M., Ridker, P. M., Manson, J. E., Hu, F. B., Fall, T., et al. (2020) · JAMA Network Open
Nutritional Studies and DietDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 54
- Verified
Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke
Zee, R. Y. L., Romero, J. R., Gould, J. L., Ricupero, D. A., & Ridker, P. M. (2006) · Stroke
Advanced Glycation End Products researchGenetic Associations and Epidemiology
Cited by 48
- Verified
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?
Blake, G. J., & Ridker, P. M. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Lipoproteins and Cardiovascular HealthBiomarkers in Disease Mechanisms
Cited by 47
- Verified
Dietary fatty acids modulate associations between genetic variants and circulating fatty acids in plasma and erythrocyte membranes: Meta‐analysis of nine studies in the CHARGE consortium
Smith, C. E., Follis, J. L., Nettleton, J. A., Foy, M., Wu, J. H. Y., Ma, Y., Tanaka, T., Manichakul, A. W., Wu, H., Chu, A. Y., et al. (2015) · Molecular Nutrition & Food Research
Fatty Acid Research and HealthNutrition, Genetics, and Disease
Cited by 46
- Verified
Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia
Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2003) · The American Journal of Medicine
Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of Life
Cited by 44
- Verified
Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans
Olfson, E., Saccone, N. L., Johnson, E. O., Chen, L.-S., Culverhouse, R., Doheny, K., Foltz, S. M., Fox, L., Gogarten, S. M., Hartz, S., et al. (2016) · Molecular Psychiatry
Smoking Behavior and CessationGenetic Associations and Epidemiology
Cited by 43
- Verified
A multi-ancestry genome-wide study incorporating gene–smoking interactions identifies multiple new loci for pulse pressure and mean arterial pressure
Sung, Y. J., de las Fuentes, L., Winkler, T. W., Chasman, D. I., Bentley, A. R., Kraja, A. T., Ntalla, I., Warren, H. R., Guo, X., Schwander, K., et al. (2019) · Human Molecular Genetics
Genetic Associations and EpidemiologyBlood Pressure and Hypertension Studies
Cited by 43
- Verified
Physical Activity and Incident Cardiovascular Disease in Women: Is the Relation Modified by Level of Global Cardiovascular Risk?
Chomistek, A. K., Cook, N. R., Rimm, E. B., Ridker, P. M., Buring, J. E., & Lee, I. ‐. (2018) · Journal of the American Heart Association
Physical Activity and HealthCardiovascular Health and Risk Factors
Cited by 36
- Verified
Expanding the triglyceride range in clinical trials: therapeutic opportunities
Nordestgaard, A. T., Pradhan, A. D., Everett, B. M., MacFadyen, J. G., Bhatt, D. L., Visseren, F. L. J., Libby, P., Santos, R. D., Nissen, S. E., Nordestgaard, B. G., et al. (2025) · European Heart Journal
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 20
- Verified
Lessons from PROMINENT and prospects for pemafibrate
Fruchart, J.-C., Fruchart-Najib, J., Yamashita, S., Libby, P., Yokote, K., Kodama, T., Tomita, Y., Ridker, P. M., Hermans, M. P., & Zambon, A. (2024) · Cardiovascular Diabetology
Peroxisome Proliferator-Activated ReceptorsLiver Disease Diagnosis and Treatment
Cited by 16
- Verified · note
Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide
Sattar, N., Linetzky, B., Ruotolo, G., Verma, S., Sourij, H., Wang, H., Vanderman, K., Wilson, J. M., Griffin, R. M., Stefanski, A., et al. (2026) · JACC
Adipokines, Inflammation, and Metabolic DiseasesPharmacology and Obesity Treatment
Cited by 5
- Verified
Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the SELECT trial
Plutzky, J., Bogdański, P., Dagdelen, S., Deanfield, J., Emerson, S., Hovingh, G., Kahn, S., Larsen, S., Latkovskis, G., Lehrke, M., et al. (2024) · Atherosclerosis
Adipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and Management
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free